J. Paul Scott, MD
Pediatric hematologist, Children's Hospital of Wisconsin; professor, Pediatrics, Medical College of Wisconsin.
Bleeding disorders research
Bleeding and blood disorders
Hemostasis, neurocognitive impact, novel therapeutics, sickle cell anemia, stroke, vascular biology.
Medical degree, Loyola University Stritch School of Medicine, Maywood, Ill., 1974; residency, Pediatrics, University of Colorado Health Sciences Center, Denver, 1974-1977; fellowship, Pediatric Hematology-Oncology, University of Colorado Medical Center, Denver, 1977-1979.
Pediatrics, 1980; Pediatric Hematology-Oncology, 1982.
Teacher of the Year, Children's Memorial Hospital; Northwestern Medical School, Department of Pediatrics, 1983; Outstanding Teacher of the Year, Children's Hospital of Wisconsin, 1998; Outstanding Teacher of the Year, Children's Hospital of Wisconsin, Medical College of Wisconsin, Department of Pediatrics, 2002.
- Talano JA, Hillery CA,Gottschall JL, Baylerian DM, Scott JP. Delayed Hemolytic Transfusion Reaction/hyperhemolysis Syndrome in Children with Sickle Cell Disease. Pediatrics. 111(6 Pt 1):e661-5, 2003.
- Melzer-Lange MD, Walsh-Kelly CM, Lea G, Hillery CA, Scott JP. Patient-controlled Analgesia for Sickle Cell Pain Crisis in a Pediatric Emergency Department. Pediatric Emergency Care. 2004 Jan.; 20(1):2-4.
- Hillery CA, Du MC, Wang WC, Scott JP. Hydroxyurea Therapy Decreases Red Blood Cell Adhesion to Thrombospondin and Laminin in Sickle Cell Disease. British Journal of Haematology. 2000; 109:322-327.
- Bevan JA, Maloney KW, Hillery CA, Gill JC, Montgomery RR, Scott JP. Bleeding Disorders: A Common Cause of Menorrhagia in Adolescents. Journal of Pediatrics. 2001 Jun.; 138(6):856-861.
- Wang WC, Wynn LW, Rogers ZR, Scott JP, Lane PA, Ware RE. A Two-year Pilot Trial of Hydroxyurea in very Young Children with Sickle Cell Anemia. Journal of Pediatrics. 2001 Dec.; 139(6):790-796.
- Scott JP, Hillery CA, Brown ER, Misiewicz V, Labotka RJ. Hydroxyurea Therapy in Children Severely Affected with Sickle Cell Disease. Journal of Pediatrics. 1996; 128:820-828.
- Wisconsin Sickle Cell Disease Comprehensive Center; current year $271,736, State of Wisconsin, Newborn Screening Program, principal investigator (25 percent effort).
- An Intervention Program for Children with Sickle Cell Disease: An Opportunity to Improve School Performance and Psychosocial Adjustment, Children's Hospital and Health System Foundation, $200,000, principal investigator.
- Mechanisms of Vaso-occlusion in Sickle Cell Disease: Role of Coagulation Pathways, NIH P01-HL44612 (PI of PPG: Peter Newman), 5/1/00 to 6/30/05; Project 4 PI: Cheryl Hillery; Co-I: JP Scott, Amount (Project 4): Direct $828,492 plus Core support, 5/1/00 to 4/30/05.
- Red Blood Cell Adhesion in Sickle Cell Disease, NIH R01-HL70981, PI: Cheryl Hillery; Co-I: J.P. Scott; 7/1/02 to 6/30/06, $900,000.
Children's Hospital of Wisconsin
PO Box 1997
Milwaukee, WI 53201-1997
Phone: (414) 937-3896
Fax: (414) 937-3804
Investigator in the areas of: